HLA antigens in Japanese patients with myasthenia gravis
about
Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravisDifferent HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravisPeptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases.Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in ChineseCTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control StudyClinical and serological study of myasthenia gravis in HuBei Province, China.Genetics of microscopic polyangiitis in the Japanese population.Autoimmune myasthenia gravis: emerging clinical and biological heterogeneityGenetics of ANCA-associated vasculitis in Japan: a role for HLA-DRB1*09:01 haplotype.Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.Suppression by mAbs against DQB1 peptides of in vitro proliferation of AChR-specific T cells from myasthenia gravis patients.Low conversion rate of ocular to generalized myasthenia gravis in Singapore.High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle-specific tyrosine kinase positive myasthenia gravis.Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis
P2860
Q28256140-2BCAEED8-D3F0-473B-BA97-F20B94FE2CC4Q28294197-0852212D-4499-40BB-941A-AB2E39CA23D9Q33536183-701AED6E-4516-4B04-AFCB-6D6B0245C235Q33591000-CB00819C-A016-49D5-A261-247AD27F8426Q33864254-310E2E1F-D74F-41F4-A1F3-85D7EBE7436AQ34503367-C1A8FB82-466E-4BCF-ABF3-8AABC1A3E825Q36014017-4336024E-F70F-462A-988A-880BAE2F0E89Q36143252-947C94FE-6E03-4478-8AAA-6B10429F5F3FQ36679437-176F67F2-92A4-4010-971B-11038B7937A8Q37315963-36F3E1EC-87F5-47E7-A1CD-CEF77496F6E0Q38062448-BB5E6271-3AA7-4F0A-9FD0-D10CC99FD0F4Q42696048-2E29927A-D3D3-46B5-8587-27E188A534A7Q46615871-A812690F-CCF6-4312-A46C-33068BA197C9Q49582626-6C15CE7E-8637-48AB-8A22-5DFEA6D7AAA3Q54334374-576679AD-3161-4AB3-8FBD-4EB1C69D4779Q58699907-3284CA05-2E92-4DA9-81C4-1944A55A16FB
P2860
HLA antigens in Japanese patients with myasthenia gravis
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
HLA antigens in Japanese patients with myasthenia gravis
@ast
HLA antigens in Japanese patients with myasthenia gravis
@en
HLA antigens in Japanese patients with myasthenia gravis
@nl
type
label
HLA antigens in Japanese patients with myasthenia gravis
@ast
HLA antigens in Japanese patients with myasthenia gravis
@en
HLA antigens in Japanese patients with myasthenia gravis
@nl
prefLabel
HLA antigens in Japanese patients with myasthenia gravis
@ast
HLA antigens in Japanese patients with myasthenia gravis
@en
HLA antigens in Japanese patients with myasthenia gravis
@nl
P2093
P2860
P356
P1476
HLA antigens in Japanese patients with myasthenia gravis
@en
P2093
Takamizawa M
Tokunaga K
P2860
P304
P356
10.1172/JCI114724
P407
P577
1990-08-01T00:00:00Z